Jump to main content
Jump to site search

Issue 8, 2015
Previous Article Next Article

Using oxidant susceptibility of thiol stabilized nanoparticles to develop an inflammation triggered drug release system

Author affiliations

Abstract

Inflammation is a complex and dynamic defensive cellular approach to safeguard against deleterious agents; however, an overexpression of such responses frequently results in the development of a number of devastating diseases, such as atherosclerosis, cancer, inflammatory bowel, Alzheimer's and Parkinson's diseases. At the site of the inflammation, excessive amount of reactive oxygen species (ROS) are produced, and therefore researchers are now earnestly trying to exploit ROS pathological signals to design oxidative triggered drug release systems. In this study, we report a straightforward strategy to develop an oxidative stress responsive drug release systems. Newly developed, ultra-small, and thiol stabilized zinc sulfide quantum dots (ZnS QDs) are used as nanocaps to regulate the release of anticancer drug (camptothecin) from mesoporous silica nanoparticles (MSNs) in response to oxidative environment. The exposure of capped nanocarrier to a higher concentration of H2O2 fails to open the drug loaded nanochannels; however, an addition of a minute amount of divalent iron, the most abundant transition-metal in the body, readily unseals the nanochannels at considerably lower H2O2 concentrations due to the generation of highly reactive hydroxyl radicals (˙OH). Thiol groups, which stabilize the ZnS nanolids, are actually oxidized by ˙OH and as a result unleash the loaded drug molecules from the channels of silica. In addition to the inflammation-induced drug delivery, this study also provides basic insight into the fate of thiol stabilized nanoparticles upon interaction with hydroxyl radicals.

Graphical abstract: Using oxidant susceptibility of thiol stabilized nanoparticles to develop an inflammation triggered drug release system

Back to tab navigation

Supplementary files

Publication details

The article was received on 15 Oct 2014, accepted on 21 Dec 2014 and first published on 23 Dec 2014


Article type: Paper
DOI: 10.1039/C4TB01709A
Author version
available:
Download author version (PDF)
J. Mater. Chem. B, 2015,3, 1597-1604

  •   Request permissions

    Using oxidant susceptibility of thiol stabilized nanoparticles to develop an inflammation triggered drug release system

    F. Muhammad, W. Qi, A. Wang, J. Gu, J. Du and G. Zhu, J. Mater. Chem. B, 2015, 3, 1597
    DOI: 10.1039/C4TB01709A

Search articles by author

Spotlight

Advertisements